DZ Bank Discount Zert BNR 27.09.2.../ DE000DQ1TBB0 /
| 13/05/2024 08:17:11 | Var.-0.02 | Denaro13:05:01 | Lettera13:05:01 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
|---|---|---|---|---|---|---|---|
| 39.39EUR | -0.05% | 39.41 Quantità in denaro: 5,000 |
39.43 Quantità in lettera: 5,000 |
BRENNTAG SE NA O.N. | - EUR | 27/09/2024 | Call |
GlobeNewswire
14:15
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of ...
GlobeNewswire
14:15
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
14:05
Company Name Change to NAPC Defense, Inc. (OTCPK: BLIS) and Website to NAPCDefense.com among Busines...
GlobeNewswire
14:05
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
14:05
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Upda...
GlobeNewswire
14:03
Tango Launches Global Choice Link, making it easy and awesome for businesses to deliver rewards, inc...
GlobeNewswire
14:02
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Confere...
GlobeNewswire
14:01
SecureW2 Wins Digital Certificate, Network Security, and Passwordless Solution Categories in 2024 Cy...
GlobeNewswire
14:00
SOUTHERN CALIFORNIA BANCORP AND CALIFORNIA BANCORP ANNOUNCE RECEIPT OF REGULATORY APPROVAL FOR MERGE...
GlobeNewswire
14:00
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
14:00
Great Pacific Gold Reports Multiple High-Grade Gold Assays from Kesar Creek Project in Papua New Gui...
GlobeNewswire
14:00
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Present...
GlobeNewswire
14:00
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
